EMA scales back activities ahead of Brexit

02-08-2018

EMA scales back activities ahead of Brexit

The European Medicines Agency (EMA) has announced plans to temporarily further scale back and suspend activities in order to cope with a more significant staff loss from the agency’s relocation than was originally expected.


EMA, European Medicines Agency, Brexit, public health, animal health, big pharma, regulation

LSIPR